drugset / Trial / NCT06281951

Nebulized Fentanyl in Healthy Volunteers

NCT06281951

Phase 1 Recruiting 20 enrolled University Hospital, Rouen
RandomizedCrossoverOpen-labelTreatment

Summary

Pain constitutes the predominant motive prompting individuals to seek emergency medical attention, accounting for 80% of admissions to emergency departments. Presently, it is imperative to employ expeditious and efficacious analgesia-sedation methodologies, obviating the necessity for intravenous administration, while ensuring the secure delivery of pharmaceutical agents. The objective of this study is to assess the feasibility and comfort of nebulized intranasal or facial aerosol administration of Fentanyl through the implementation of a pharmacokinetic/pharmacodynamic (PK/PD) study

Timeline

Start
2024-04-26
Primary completion
2027-06-01
Completion
2027-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 20 ug Inhaled
Subject Fentanyl Other / unclassified 30 ug Inhaled
Subject Fentanyl Other / unclassified 40 ug Inhaled
Subject Fentanyl Other / unclassified 50 ug Inhaled

Indications

No indication recorded.